Insider trading

Period: 12 months Stock: OCUL + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

29 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

29 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

29 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

29 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
29 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
29 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

29 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Oct 2026
Heier Jeffrey S. Chief Scientific Officer
Sold on a plan
$76.63K 10,869 at 7.05
3.4%
Planned (10b5-1)
2 Oct 2026
Kaiser Peter Chief Development Officer
Sold on a plan
$70.43K 9,990 at 7.05
3.8%
Planned (10b5-1)
31 Aug 2026
Notman Donald Chief Operating Officer
Sold at will
$11.25K 1,099 at 10.24
0.3%
Not planned
24 Aug 2026
Dugel Pravin See Remarks
Sold on a plan
$233.16K 21,649 at 10.77
0.9%
Planned (10b5-1)
24 Aug 2026
Heier Jeffrey S. Chief Scientific Officer
Sold on a plan
$35.53K 3,296 at 10.78
1.0%
Planned (10b5-1)
24 Aug 2026
Kaiser Peter Chief Development Officer
Sold on a plan
$32.69K 3,035 at 10.77
1.1%
Planned (10b5-1)
24 Aug 2026
Nayak Sanjay Chief Strategy Officer
Sold on a plan
$20.45K 1,897 at 10.78
0.6%
Planned (10b5-1)
3 Jun 2026
Waheed Nadia Chief Medical Officer
Sold on a plan
$122.63K 14,828 at 8.27
4.7%
Planned (10b5-1)
26 May 2026
Dugel Pravin See Remarks
Sold on a plan
$173.48K 21,156 at 8.20
0.8%
Planned (10b5-1)
26 May 2026
Heier Jeffrey S. Chief Scientific Officer
Sold on a plan
$24.75K 3,018 at 8.20
0.9%
Planned (10b5-1)
26 May 2026
Kaiser Peter Chief Development Officer
Sold on a plan
$24.33K 2,967 at 8.20
1.1%
Planned (10b5-1)
26 May 2026
Nayak Sanjay Chief Strategy Officer
Sold on a plan
$15.24K 1,858 at 8.20
0.6%
Planned (10b5-1)
23 Feb 2026
Dugel Pravin See Remarks
Sold on a plan
$166.06K 20,056 at 8.28
0.7%
Planned (10b5-1)
23 Feb 2026
Heier Jeffrey S. Chief Scientific Officer
Sold on a plan
$25.31K 3,057 at 8.28
0.9%
Planned (10b5-1)
23 Feb 2026
Kaiser Peter Chief Development Officer
Sold on a plan
$23.27K 2,810 at 8.28
1.0%
Planned (10b5-1)
23 Feb 2026
Nayak Sanjay Chief Strategy Officer
Sold on a plan
$14.56K 1,759 at 8.28
0.5%
Planned (10b5-1)
20 Feb 2026
Bought
$461.35K 60,229 at 7.66
32.3%
Largest buy in 3 yrs
20 Feb 2026
Waheed Nadia Chief Medical Officer
Sold on a plan
$27.17K 3,510 at 7.74
1.1%
Planned (10b5-1)
12 Feb 2026
Dugel Pravin See Remarks
Sold on a plan
$1.13M 124,882 at 9.04
4.0%
Planned (10b5-1)
12 Feb 2026
Notman Donald Chief Operating Officer
Sold at will
$103.47K 11,446 at 9.04
3.0%
Not planned
12 Feb 2026
Nayak Sanjay Chief Strategy Officer
Sold on a plan
$93.55K 10,348 at 9.04
3.0%
Planned (10b5-1)
12 Feb 2026
Waheed Nadia Chief Medical Officer
Sold on a plan
$71.08K 7,863 at 9.04
2.4%
Planned (10b5-1)
4 Feb 2026
Notman Donald Chief Operating Officer
Sold at will
$51.54K 6,035 at 8.54
1.6%
Not planned
2 Feb 2026
Notman Donald Chief Operating Officer
Sold at will
$49.86K 5,455 at 9.14
1.4%
Not planned
24 Nov 2025
Dugel Pravin See Remarks
Sold on a plan
$235.14K 19,530 at 12.04
0.6%
Planned (10b5-1)
24 Nov 2025
Heier Jeffrey S. Chief Scientific Officer
Sold on a plan
$41.77K 3,469 at 12.04
1.4%
Planned (10b5-1)
24 Nov 2025
Kaiser Peter Chief Development Officer
Sold on a plan
$36.14K 3,007 at 12.02
1.5%
Planned (10b5-1)
24 Nov 2025
Nayak Sanjay Chief Strategy Officer
Sold on a plan
$22.61K 1,878 at 12.04
0.7%
Planned (10b5-1)
5 Nov 2025
Saroj Namrata Chief Business Officer
Sold on a plan
$277.79K 25,865 at 10.74
12.9%
Planned (10b5-1)
Showing 1–29 of 29.